Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Divi's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	532488
ISIN Demat	INE361B01024
Book Value	536.00

NSE Code	DIVISLAB
Dividend Yield %	0.49
Market Cap	1614048.97

P/E	77.86
EPS	78.09
Face Value	2


	BSE		NSE

07-May-2025 10:29

Last Price	6095.50
Net Change	-60.4
% Change	-0.98%
Prev.Close	6155.90
Open	6011.65
High	6153.00
Low	6011.65
Volume	876

Last Price	6075.00
Net Change	-86
% Change	-1.4%
Prev.Close	6161.00
Open	6085.00
High	6157.50
Low	6064.50
Volume	68443

Value	5339658
Best Buy	6082.80
Best Sell	6090.40
Best Quantity	15
Sell Quantity	13
Today's Range	6153.00
52-Week High	6448.75
52-Week Low	3725.55

Value	415791225
Best Buy	6074.50
Best Sell	6076.00
Best Quantity	52
Sell Quantity	21
Today's Range	6157.50
52-Week High	6308.50
52-Week Low	3724.00

Open Price	6098.50
High Price	6169.50
Low Price	6086.50
Last Price	6158.50
Prev Close	6171.00
Change	-12.50
% Change	-0.20 %

Average Price	6130.63
Underlying Value	6075.00
Number of contracts traded	962
Turnover in Rs. Lakhs	5898
Open Interest	3085900.00
Change in O I	-14700.00
% Change in O I	-0.47 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	15
Price	6082.80

Quantity	13
Price	6090.40

Best Bid

Best Offer

Quantity	52
Price	6074.50

Quantity	21
Price	6076.00

Best Bid

Best Offer

Quantity	100
Price	6153

Quantity	100
Price	6158

Holding Details

Latest Corporate Events

Bonus

1 : 1

23-Sep-15

Book Closure

20-Aug-21

22-Aug-21

Dividend

1500 %

02-Aug-24

Company News

30-04-2025

Divi's Laboratories infor...

21-04-2025

Divi's Laboratories inks ...

21-04-2025

Divi's Laboratories surge...

31-03-2025

Divi's Laboratories infor...

31-03-2025

Divis Laboratories inform...

21-02-2025

Divi's Laboratories infor...

03-02-2025

Divi's Laboratories infor...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.